SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study

Published:2017-06-30 Issue:1 Volume:16 Page:
ISSN:2251-6581
Container-title:Journal of Diabetes & Metabolic Disorders
language:en
Short-container-title:J Diabetes Metab Disord

Author:

Tamez-Perez Héctor Eloy,Delgadillo-Esteban Enrique,Soni-Duque David,Hernández-Coria Mayra Ivonne,Tamez-Peña Alejandra Lorena

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40200-017-0308-4.pdf

Reference15 articles.

1. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:31.

2. McGovern A, et al. Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use. Diabetes Therapy. 2017;8(2):365–76.

3. American Diabetes Association. Glycemic targets. Sec. 5. In Standards of Medical Care in Diabetes −2016. Diabetes Care. 2016;39(Suppl. 1):S39–46.

4. Gallo LA, Wright EM, Vallon V. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences. Diabetes Vasc Dis Res. 2015;12(2):78–89. doi: 10.1177/1479164114561992 .

5. Gurgle HE, White K, McAdam-Marx C. SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives. Vasc Health Risk Manag. 2016;12:239–49. doi: 10.2147/VHRM.S83088 .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials;European Journal of Clinical Pharmacology;2023-04-25

2. Effect of sodium–glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis;Acta Diabetologica;2022-10-20

3. Life-threatening complications for diabetic patients taking SGLT2 inhibitors when undergoing surgery: A poorly recognised problem?;Journal of Perioperative Practice;2022-03-15

4. Effect of Luseogliflozin on liver function, BNP and baPWV in diabetics with coronary artery disease;Vascular Failure;2021-08-31

5. Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan;Pakistan Journal of Medical Sciences;2021-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3